Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection

Clinical Infectious Diseases

Volumn 27, Issue 5, 1998, Pages 1161-1167

  Schuman, Paula ^a   Sobel, Jack D ^b   Ohmit, Suzanne E ^b   Mayer, Kenneth H ^b   Carpenter, Charles C J ^b   Rompalo, Anne ^b   Duerr, Ann ^b   Smith, Dawn K ^b   Warren, Dora ^b   Klein, Robert S ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CANDIDA; CANDIDIASIS; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INSULIN TREATMENT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; PHARYNGITIS; PRIORITY JOURNAL; SEXUAL BEHAVIOR; THRUSH; VAGINA CANDIDIASIS;

EID: 0032450445     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/514979     Document Type: Article

References (40)

1. Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994; 97:339-46.
2. Powderly WG, Robinson K, Keath EJ. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis 1993; 168: 463-6.
3. Whelan WL, Kirsch DR, Kwon-Chung KJ, Wahl SM, Smith PD. Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel or hypervirulent strain. J Infect Dis 1990; 162: 513-8.
4. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311:354-8.
5. Dupont B, Graybill JR, Armstrong D, Laroche R, Touze JE, Wheat LJ. Fungal infections in AIDS patients. J Med Vet Mycol 1992; 30:19-28.
6. Selik RM, Starcher ET, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations, trends. AIDS 1987; 1:175-82.
7. Van Meter F, Gallo JW, Garcia-Rojas G, Tan MM, Silverman S Jr. A study of oral candidiasis in HIV-positive patients. J Dent Hyg 1994; 68:30-4.
8. Samaranayake LP, Holmstrup P. Oral candidiasis and human immunodeficiency virus infection. J Oral Pathol Med 1989; 18:554-64.
9. Tylenda CA, Larsen J, Yeh CK, Lane HC, Fox PC. High levels of oral yeasts in early HIV-1 infection. J Oral Pathol Med 1989; 18:520-4.
10. Pindborg JJ. Oral candidiasis-HIV infection. In: Robertson PB, Greenspan JS, eds. Perspectives on oral manifestations of AIDS. Littleton, MA: Littleton PSG Publishing, 1988:2837.
11. Nielsen H, Bentsen KD, Hojtved L, et al. Oral candidiasis and immune status of HIV-infected patients. J Oral Pathol Med 1994; 23:140-3.
12. + lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992; 165:352-63.
13. Lifson RA, Hilton JF, Westernhouse JL, et al. Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994; 8: 73-9.
14. Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome: experience with 5,833 cases in New York City. N Engl J Med 1987; 317:1297-302.
15. Lifson AR, Rutherford GW, Jaffe HW. The natural history of human immunodeficiency virus infection. J Infect Dis 1988; 158:1360-7.
16. Greenspan D. Treatment of oropharyngeal candidiasis in HIV-positive patients. J Am Acad Dermatol 1994; 31:551-5.
17. Rhoads JL, Wright DC, Redfield RR, Burke DS. Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA 1987; 257:3105-7.
18. Carpenter CC, Mayer KH, Fisher A, Desai MB, Durnad L. Natural history of acquired immunodeficiency syndrome in women in Rhode Island. Am J Med 1989; 86:771-5.
19. Imam N, Carpenter CC, Mayer KH, Fisher A, Stein M, Danforth SB. Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990; 89:142-6.
20. Spinillo A, Michelone O, Cavanna C, Colonna L, Capuzzo E, Nicola S. Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV seropositive women. Genitourin Med 1994; 70: 268-72.
21. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41(RR-17):1-19.
22. Hurley R, Delouvois J. Candida vaginitis. Postgrad Med J 1979; 55: 645-7.
23. Geiger AM, Foxman B. Risk factors in vulvovaginal candidiasis: a case-control study among college students. Epidemiol 1996; 7:182-7.
24. Horowitz B, Edelstein SW, Lippman L. Sexual transmission of Candida. Obstet Gynecol 1987; 69:883-6.
25. Spinillo A, Capuzzo F, Nicola S, Baltaro F, Ferrari A, Monaco A. The impact of oral contraception on vulvovaginal candidiasis. Contraception 1995; 51:293-7.
26. Hawes SE, Hillier SL, Beneditti J, et al. Hydrogen peroxide-produced lactobacilli and acquisition of vaginal infections. J Infect Dis 1996; 174: 1058-63.
27. Spinillo A, Carrata L, Pizzoli G. Recurrent vulvovaginal candidiasis: results of a cohort study of sexual transmission and intestinal reservoir. J Reprod Med 1992; 37:343-7.
28. Smith DK, Warren D, Vlahov D, et al. Design and baseline participant characteristics of the HIV Epidemiology Research (HER) Study: a prospective cohort study of HIV infection in US women. Am J Epidemiol 1997; 146:459-69.
29. SAS Institute, Inc. SAS statistical software, release 6.0. Cary, NC: SAS Institute, 1988.
30. Statistics and Epidemiology Research Corporation [SERC]. EGRET statistical software. Seattle: SERC, 1988.
31. Schuman P, Ohmit SE, Sobel JD, et al. Oral lesions in women living with or at risk for HIV infection. Am J Med 1998; 104:559-64.
32. Phelan JA, Salzman BR, Friedland GH, Klein RS. Oral findings in patients with acquired immunodeficiency syndrome. Oral Surg Oral Med Oral Pathol 1987; 64:50-6.
33. Feigal DW, Katz MH, Greenspan D, et al. The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiologic cohorts. AIDS 1991; 5:519-25.
34. Korting HC, Ollert M, Georgii A, Froschl M. In vitro susceptibilities and biotypes of Candida albicans from oral cavities of persons infected with human immunodeficiency virus. J Clin Microbiol 1988; 26: 2626-31.
35. Drake TE, Maibach HI. Candida and candidiasis. 1. Cultural conditions, epidemiology and pathogenesis. Postgrad Med 1973; 53:83-7.
36. Brawner DL, Cutler JE. Oral Candida albicans isolates from non-hospitalized normal carriers, immunocompetent hospitalized patients and immunocompromised patients with or without acquired immunodeficiency syndrome. J Clin Microbiol 1989; 27:1335-41.
37. Miyasaki SH, Hicks JB, Greenspan D, et al. The identification and tracking of Candida albicans isolates from oral lesions in HIV-seropositive individuals. J Acquir Immune Defic Syndr 1992; 5:1039-46.
38. Schuman P, Capps L, Peng G, et al. Weekly fluconazole in the prevention of mucosal candidiasis in women with HIV infection. Ann Intern Med 1997; 126:689-96.
39. El-Sadr W, Schuman P, Peng G, Capps L, Neaton J. Predictors of mucosal candidiasis among HIV-infected women [abstract]. In: Proceedings of the National Conference on Women and HIV (Los Angeles). 1997.
40. Duerr A, Sierra MF, Feldman J, Clarke LM, Ehrlich I, DeHovitz J. Immune compromise and prevalence of Candida vulvovaginitis in human immunodeficiency virus-infected women. Obstet Gynecol 1997; 90:252-6.